Login
欢迎浏览恩派尔生物资料网
我要投稿 请登录 免费注册 安全退出

您现在的位置是: 首页 > 实验方法 > 细胞技术

细胞技术

Pharmacogenetic Analysis of Clinically Relevant Genetic Polymorphisms

2025-03-15 细胞技术 加入收藏
With the recent publication of the human genome sequence, there has been an expa

With the recent publication of the human genome sequence, there has been an expanse of publicly available resources for pharmacogenomics research. Early estimates predicted that over 3 million single nucleotide polymorphisms (SNPs) are present in the human genome, with over 1.42 million already deposited in the public databases (1 ). SNPs in coding and control regions of genes can cause significant inter-individual variation in the resulting protein function and activity, leading to important differences in disease susceptibility and drug metabolism. This expansion in valuable SNPs has stimulated the development of a number of detection methods (2 ). We describe protocols for three distinct methods (allele-specific polymerase chain reaction (PCR), PCR-restriction fragment length polymorphism (PCR-RFLP), and Pyrosequencing) as examples of ways to assay clinically relevant polymorphisms.

文章底部广告位

文章评论

加载中~